Neurocarrus
What is Neurocarrus?Treating Neurodegenerative Disease and Pain Without Addiction.Neurocarrus is a biotech company developing a novel drug technology to safely target neurodegeneration and pain without risk of addiction or other systemic effects.Learn More Our crowd funding raise has started.
About Neurocarrus
Recent Funding lists Neurocarrus under Health and bio. It went through IndieBio (IndieBio SF 06). It was founded by Paul Blum.
Funding rounds
- IndieBio SF 06
IIndieBio · batchSource: indiebio.co - X account created
- Website created
Founders and team
PB
Paul Blum CEO and Co-Foundersource: neurocarrus.com
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
BBioStack$9.5M Seed · Oct 2026HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026
WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
Questions and sources
Neurocarrus: questions and answers
- Who invested in Neurocarrus?
- Investors on record for Neurocarrus: IndieBio.
- Who founded Neurocarrus?
- Neurocarrus was founded by Paul Blum (CEO and Co-Founder).
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/neurocarrus-inc (get a free API key).